The 3rd European Hepatitis C Community Summit was held in Marseille, on 25 and 26 November 2019. The aim of the Summit was to bring together researcher, health and community workers, medical staff and HCV patients and advocates to discuss elimination of the disease and role of harm reduction and community services. The event was organised by Correlation – European Harm Reduction Network, in cooperation with the European Union funded Eurosider project.
The programme contained plenary and parallel sessions and focused on priorities for community involvement and advocacy targets for after the event.
A variety of examples of good practice was presented during parallel sessions on: Models of good practice, HCV in prison, Peer Involvement works – we just need to implement it, Capacity building, Access to services, ODBuster – Digitally Networking the Response to Opioid Overdose Emergencies, HCV prevention for (un) documented migrants and Building Capacity to support People who use drugs. Probably the most interesting one was on HCV in prison.
Several representatives of DPNSEE member organisations participated, including Aksion Plus, Margina, Proi, Prometheus, Juventas, HOPS, Positive Voice, ARAS and Alliance of Non Governmental Organisations for Drugs and Addictions in Slovenia. The DPNSEE Board member Marios Atzemis was member of the planning team of the Summit.
The French Embassy in Belgrade provided support for two representatives from Serbia. One was from the Institute for Public Health while the second was DPNSEE Executive Director Milutin Milošević.
At the Summit, a statement about the negative effects of criminalisation on health and well being of people who use drugs entitled The decriminalisation of drug use and ensuring national funding of key services will reduce death, disease and marginalisation of people who use drugs was launched – without any opportunity to discuss it.